CAS 1265295-20-2

Selexipag metabolite ACT-333679 D7

Description:

Selexipag metabolite ACT-333679 D7, identified by the CAS number 1265295-20-2, is a chemical compound that serves as a metabolite of the drug selexipag, which is primarily used in the treatment of pulmonary arterial hypertension. This metabolite is characterized by its structural modifications that occur during the metabolic process, which can influence its pharmacological properties. Typically, metabolites like ACT-333679 D7 may exhibit altered potency, efficacy, or safety profiles compared to their parent compounds. The compound is likely to possess specific functional groups that contribute to its solubility, stability, and interaction with biological targets. Additionally, its metabolic pathways may involve enzymatic processes that can affect its half-life and bioavailability. Understanding the characteristics of such metabolites is crucial for evaluating their role in therapeutic outcomes and potential side effects in clinical settings. Further studies may be necessary to elucidate its complete pharmacokinetic and pharmacodynamic profiles.

Formula: C₂₅H₂₉N₃O₃

Synonyms:

• Selexipag metabolite ACT-333679 D7

[4-[(5,6-Diphenyl-2-pyrazinyl)(isopropyl-d7)amino]butoxy]acetic Acid

CAS: 1265295-20-2

Purity: 99 atom % D

Molecular weight: 426.56

Ref: 3U-D8144